GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
(LLY) - Analyzing Eli Lilly's Short Interest
(PFE) - Analyzing Pfizer's Short Interest
Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick
S&P 500, Dow Hit Records Right After Open | Live Stock
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
ひな☆彡 SOXL(Bull) : I see it slightly differently. It might pull back a little before blasting off
MonkeyGee OP ひな☆彡 SOXL(Bull) : That could happen also. No one knows except the men in black.